These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 31301362)

  • 41. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
    Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
    J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
    Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
    Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
    Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
    Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1.
    Park YJ; Kim EK; Bae JY; Moon S; Kim J
    Cancer Lett; 2016 Jan; 370(2):222-31. PubMed ID: 26519755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo regulation of hTERT expression and telomerase activity by androgen.
    Guo C; Armbruster BN; Price DT; Counter CM
    J Urol; 2003 Aug; 170(2 Pt 1):615-8. PubMed ID: 12853842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter.
    Zhang P; Chen Y; Jiang X; Tu Z; Zou L
    Oncol Rep; 2010 May; 23(5):1309-16. PubMed ID: 20372845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
    Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
    Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
    Liu L; Liu C; Lou F; Zhang G; Wang X; Fan Y; Yan K; Wang K; Xu Z; Hu S; Björkholm M; Xu D
    J Pathol; 2011 Oct; 225(2):203-11. PubMed ID: 21590772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
    Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
    Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LIN28B promotes the progression of colon cancer by increasing B-cell lymphoma 2 expression.
    Yuan L; Tian J
    Biomed Pharmacother; 2018 Jul; 103():355-361. PubMed ID: 29669301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rab27A mediated by NF-κB promotes the stemness of colon cancer cells via up-regulation of cytokine secretion.
    Feng F; Jiang Y; Lu H; Lu X; Wang S; Wang L; Wei M; Lu W; Du Z; Ye Z; Yang G; Yuan F; Ma Y; Lei X; Lu Z
    Oncotarget; 2016 Sep; 7(39):63342-63351. PubMed ID: 27556511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
    Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.